New PET scan aims to sharpen bladder cancer staging
NCT ID NCT04018053
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 21 times
Summary
This early-phase study tests a special PET scan (using 18F-fluciclovine) to see if it can more accurately show how far muscle-invasive bladder cancer has spread, compared to standard CT or MRI scans. Sixteen adults with bladder cancer scheduled for bladder removal surgery will get the new scan first. The goal is to see if the scan matches what surgeons find during the operation, potentially improving future staging and treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.